RESUMO
Gastrointestinal bleeding is among the major clinical challenges for the gastroenterologists and the initial approach is very complex. For a big part of bleeding lesions, it is important to perform an endoscopic hemostatis after the introduction of an intravenous treatment (that has to be started as soon as there is a clinical suspicion of an upper gastrointestinal bleeding). The significant progresses made during the last years have allowed firstly to see the entire small bowel mucosa (video capsule) and secondly new treatments have successfully replaced surgical interventions.
Assuntos
Hemorragia Gastrointestinal/etiologia , Hemorragia Gastrointestinal/terapia , Doença Aguda , Endoscopia Gastrointestinal , Hemorragia Gastrointestinal/diagnóstico , Humanos , Melena/diagnóstico , Melena/etiologiaRESUMO
The treatment of reflux disease did not change in the review period. PPI therapy remains the first line treatment and surgery the second line approach. Endoscopic anti-reflux procedures should be only performed in controlled studies. Beside the classic triple therapy, sequential treatment of Helicobacter pylori infection can today be considered as a first line therapy. PPI are effective in the prevention of gastroduodenal lesions and in the treatment of dyspeptic symptoms induced by NSAIDs treatment. Only patients younger then 65 years and without any risk factors do not need a preventive PPI prescription during classic NSAIDS treatment.
Assuntos
Refluxo Gastroesofágico/terapia , Antiulcerosos/uso terapêutico , Procedimentos Cirúrgicos do Sistema Digestório , Infecções por Helicobacter/tratamento farmacológico , Humanos , Inibidores da Bomba de Prótons/uso terapêuticoRESUMO
A new generation of PPI are presently in clinical trials. They are characterized by a quicker and longer effectiveness, very useful for reflux disease treatment. We have to note that the enthusiasm towards the endoscopy treatment for reflux disease is clearly deceasing and two types of procedures have even been recalled from the market. In Helicobacter pylori eradication treatments the tendency tends towards high doses of antibiotics for the second option treatments. The indication for a COX-2 treatment is largely reduced due to the cardiac side effects of certain COX-2. For the patients with high risk of gastro-duodenal toxicity through AINS, the alternative remains the classical non-specific AINS treatment associated with a PPI.
Assuntos
Inibidores Enzimáticos/uso terapêutico , Doenças do Esôfago/terapia , Inibidores da Bomba de Prótons , Gastropatias/terapia , Úlcera Gástrica/tratamento farmacológico , Ensaios Clínicos como Assunto , Inibidores de Ciclo-Oxigenase 2/efeitos adversos , Inibidores de Ciclo-Oxigenase 2/uso terapêutico , Doenças do Esôfago/fisiopatologia , Infecções por Helicobacter/tratamento farmacológico , Humanos , Fatores de Risco , Gastropatias/fisiopatologiaRESUMO
The therapeutical acquisitions of the year 2004 are: 1. The sequential treatment of the Helicobacter pylori infection reaches an eradication rate of 95%. 2. The use of COX-2 inhibitors reduced significantly the gastrointestinal side effects of anti-inflammatory treatments. Since cardiac averse effects of certain COX-2 inhibitors had been reported, the treatments with COX-2 inhibitors came widely into question. In the case of patients with risk of NSAID induced gastrointestinal toxicity, the alternative is to return to a treatment with non specific NSAID associated to an prophylactic PPI treatment.
Assuntos
Anti-Inflamatórios não Esteroides/efeitos adversos , Inibidores de Ciclo-Oxigenase/uso terapêutico , Infecções por Helicobacter/tratamento farmacológico , Gastropatias/tratamento farmacológico , Anti-Inflamatórios não Esteroides/uso terapêutico , Esôfago de Barrett/cirurgia , Refluxo Gastroesofágico/cirurgia , Helicobacter pylori/patogenicidade , Humanos , Úlcera Gástrica/etiologia , Úlcera Gástrica/microbiologia , Úlcera Gástrica/prevenção & controleRESUMO
BACKGROUND AND STUDY AIMS: Barrett's esophagus is strongly associated with adenocarcinoma. Early malignant transformation of the Barrett's mucosa is often not visible endoscopically and may remain undetected until the invasive adenocarcinoma stage. Endoscopic surveillance is currently carried out on random four-quadrant biopsies at 1-2 cm intervals. Endoscopic fluorescence detection of protoporphyrin IX induced by 5-aminolevulinic acid can identify premalignant lesions. This study evaluates endoscopic fluorescence detection in patients having Barrett's esophagus and compares the results to those of standard endoscopy with random four-quadrant biopsies. PATIENTS AND METHODS: The study included 30 examinations in 28 patients (22 men, 6 women; age range 37-78 years, mean age 60 years,), with five patients having known intraepithelial neoplasia. A dose of 20 mg/kg of 5-aminolevulinic acid was given orally 5 hours before examination. Random four-quadrant biopsies were performed 4-6 weeks before endoscopic fluorescence detection. RESULTS: Of the biopsies taken during the endoscopic fluorescence detection procedure, 28 % (23/81) were true positives. More than one-third of the false-positive results were due to inflammation. None of the 97 control biopsies taken on nonfluorescing areas during endoscopic fluorescence detection were dysplastic. Endoscopic fluorescence detection showed low-grade intraepithelial neoplasia in five patients which was not diagnosed with random four-quadrant biopsies, while random four-quadrant biopsies alone showed three low-grade intraepithelial neoplasias that were invisible during endoscopic fluorescence detection. All high-grade intraepithelial neoplasias or adenocarcinomas (2/2) were detected with both methods. CONCLUSIONS: Fluorescence detection achieved a similar performance when compared with four-quadrant random biopsy, but resulted in fewer biopsies (81 for endoscopic fluorescence detection vs 531 for random four-quadrant biopsies).
Assuntos
Ácido Aminolevulínico/administração & dosagem , Esôfago de Barrett/complicações , Esôfago de Barrett/diagnóstico por imagem , Carcinoma in Situ/diagnóstico por imagem , Carcinoma in Situ/etiologia , Neoplasias Esofágicas/diagnóstico por imagem , Neoplasias Esofágicas/etiologia , Esofagoscopia , Fluorescência , Fármacos Fotossensibilizantes/administração & dosagem , Protoporfirinas/administração & dosagem , Administração Oral , Adulto , Idoso , Esôfago de Barrett/patologia , Carcinoma in Situ/patologia , Neoplasias Esofágicas/patologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Valor Preditivo dos Testes , Radiografia , Reprodutibilidade dos TestesRESUMO
BACKGROUND: Rapid and consistent acid suppression on the first day of dosing may be important in treating acid-related disorders. AIM: To compare the antisecretory activity and onset of action of single doses of rabeprazole, lansoprazole, pantoprazole, omeprazole capsule, omeprazole multiple unit pellet system (MUPS) tablet and placebo in healthy Helicobacter pylori-negative subjects. METHODS: This cross-over, double-blind, randomized study was performed in 18 H. pylori-negative subjects. Twenty-four-hour intragastric pH monitoring was performed on the day of treatment (once-daily dose of rabeprazole 20 mg, lansoprazole 30 mg, pantoprazole 40 mg, omeprazole capsule 20 mg, omeprazole MUPS tablet 20 mg or placebo). RESULTS: The intragastric pH (3.4) and time at pH > 4 during the 24 h post-dose (8.0 h) were significantly greater with rabeprazole than with lansoprazole, pantoprazole, omeprazole capsule, omeprazole MUPS tablet or placebo (P Assuntos
Antiácidos/administração & dosagem
, Ácido Gástrico/metabolismo
, Inibidores da Bomba de Prótons
, 2-Piridinilmetilsulfinilbenzimidazóis
, Adolescente
, Adulto
, Benzimidazóis/administração & dosagem
, Estudos Cross-Over
, Método Duplo-Cego
, Feminino
, Humanos
, Concentração de Íons de Hidrogênio
, Lansoprazol
, Masculino
, Pessoa de Meia-Idade
, Omeprazol/administração & dosagem
, Omeprazol/análogos & derivados
, Pantoprazol
, Rabeprazol
, Sulfóxidos/administração & dosagem
, Fatores de Tempo
RESUMO
BACKGROUND AND AIMS: This was a prospective blinded study to compare computed tomography (CT) colonography, performed with multidetector arrays CT scan (MDCT), with conventional colonoscopy for the detection of colorectal neoplasia. METHODS: Fifty patients were examined by MDCT after standard bowel preparation and rectal air insufflation in the supine and prone positions. Data sets were examined by one radiologist and one gastroenterologist blinded to the patient's history and colonoscopy results. Patients subsequently underwent colonoscopy on the same day, which served as the gold standard. RESULTS: Nine of 11 lesions >10 mm (82%), 5/15 lesions of 6-9 mm (33%), and 1/42 polyps <5 mm (3%) were detected by MDCT colonography. One false positive result for a structure larger than 10 mm was described. Nineteen of 21 patients who had no lesions during conventional colonoscopy were considered free of lesions by MDCT colonography, yielding a per patient specificity of 90%. CONCLUSION: MDCT colonography provides good data quality and has good sensitivity and specificity for the detection of colonic lesions of 10 mm or more.
Assuntos
Colonografia Tomográfica Computadorizada , Colonoscopia , Neoplasias Colorretais/diagnóstico , Idoso , Neoplasias Colorretais/diagnóstico por imagem , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Sensibilidade e Especificidade , Método Simples-CegoRESUMO
BACKGROUND AND STUDY AIMS: Guidelines for antibiotic prophylaxis of infective endocarditis associated with gastrointestinal endoscopy are not uniform. Though based on weak scientific evidence, they do represent an attempt to unify the management of antibiotic prophylaxis. We investigated whether physicians who profess to adhere to these guidelines actually do apply them correctly. MATERIALS AND METHODS: A questionnaire was sent to all 195 Swiss gastroenterologists asking whether they adhered to antibiotic prophylaxis guidelines and under what conditions did they apply antibiotic prophylaxis in gastrointestinal endoscopy. We analysed whether the Swiss gastroenterologists who claim to adhere to these guidelines actually do so in practice. RESULTS: The response rate to our questionnaire was 95%. Of the Swiss gastroenterologists, 60% correctly employ antibiotic prophylaxis guidelines in gastroscopy, as do 47% in colonoscopy. In therapeutic endoscopy, the percentage of correct antibiotic prophylaxis use depends upon the type of intervention and varies between 21 and 58%. Overuse of antibiotic prophylaxis is at least twice as frequent in colonoscopy and therapeutic endoscopy than in gastroscopy. CONCLUSIONS: Guidelines for antibiotic prophylaxis are not well applied and do not lead to uniform management despite a high degree of professed adherence to them. This phenomenon can be explained by "cognitive dissonance" and "reactance." We conclude that guidelines based on unconvincing data may even prove harmful.
Assuntos
Antibioticoprofilaxia/estatística & dados numéricos , Endocardite Bacteriana/prevenção & controle , Endoscopia Gastrointestinal/efeitos adversos , Fidelidade a Diretrizes/estatística & dados numéricos , Mau Uso de Serviços de Saúde/estatística & dados numéricos , Antibioticoprofilaxia/normas , Revisão de Uso de Medicamentos , Endocardite Bacteriana/tratamento farmacológico , Endoscopia Gastrointestinal/métodos , Feminino , Gastroenterologia/normas , Gastroenterologia/tendências , Pesquisas sobre Atenção à Saúde , Humanos , Masculino , Probabilidade , Inquéritos e Questionários , SuíçaRESUMO
31 cases of non-fulminant hepatitis A complicated by acute renal insufficiency are reported in the literature. Two-thirds of those patients needed dialysis, usually when depending on the severity of their hyperbilirubinemia. This report concerns the first published case of non-fulminant cholestatic hepatitis A complicated by acute renal insufficiency in which a spontaneous remission of renal function occurred without need for dialysis despite a very severe hyperbilirubinemia.
Assuntos
Injúria Renal Aguda/complicações , Colestase Intra-Hepática/complicações , Hepatite A/complicações , Injúria Renal Aguda/diagnóstico , Adulto , Colestase Intra-Hepática/diagnóstico , Seguimentos , Hepatite A/diagnóstico , Humanos , Testes de Função Renal , Testes de Função Hepática , Masculino , Diálise RenalRESUMO
BACKGROUND: Oral sodium phosphate solution (NAP) and polyethylene glycol-electrolyte lavage (PEG-EL) are used for precolonoscopy bowel preparation. The benefit of adding cisapride to PEG-EL is controversial, and its influence on the effectiveness of NAP has not been investigated. The primary aim of this study was to determine whether cisapride improves the effectiveness and/or tolerableness of bowel preparation with either NAP or PEG-EL. METHODS: In 187 patients undergoing colonoscopy, a randomized, double-blind, placebo-controlled trial with a Latin square design was conducted to compare 4 different bowel preparations: NAP plus either cisapride (10 mg; 2 doses) or placebo, or PEG-EL plus either cisapride (10 mg; 1 dose) or placebo. Quality of the bowel preparation was graded by the endoscopist according to the amount of stool present in the colon (excellent, satisfactory, unsatisfactory). To assess tolerability, patients rated 8 symptoms, the taste of the lavage solution, and the ease of preparation on a 5-point scale (1: easy; 5: distressing). RESULTS: Endoscopists scored the bowel preparation as either excellent or satisfactory as follows: NAP: cisapride 50% versus placebo 61% (p = 0.3); PEG-EL: cisapride 80% versus placebo 78% (p = 1.0). Cisapride did not improve tolerability or the frequency of adverse symptoms associated with either solution. The ease of bowel preparation was significantly better in the NAP group versus PEG-EL group (mean score 1.8 versus 2.8; p < 0.0001). CONCLUSIONS: Cisapride does not improve the quality of bowel preparation with either NAP or PEG-EL. NAP is better tolerated by patients than PEG-EL; however, PEG-EL results in better bowel preparation.
Assuntos
Cisaprida/administração & dosagem , Colonoscopia , Fosfatos/administração & dosagem , Polietilenoglicóis/administração & dosagem , Irrigação Terapêutica/métodos , Administração Oral , Método Duplo-Cego , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Aceitação pelo Paciente de Cuidados de Saúde , Fosfatos/efeitos adversos , Polietilenoglicóis/efeitos adversos , SoluçõesRESUMO
BACKGROUND: Patients referred for chronic constipation frequently report symptoms of straining, feeling of incomplete evacuation, or the need to facilitate defecation digitally (dyschezia). When such patients show manometric evidence of inappropriate contraction or failure to relax the pelvic floor muscles during attempts to defecate, they are diagnosed as having pelvic floor dyssynergia (Rome I). AIMS: To evaluate long-term satisfaction of patients with pelvic floor dyssynergia after biofeedback. PATIENTS: Forty-one consecutive patients referred for chronic constipation at an outpatient gastrointestinal unit and diagnosed as having pelvic floor dyssynergia who completed a full course of biofeedback. METHODS: Data have been collected using a standardised questionnaire. A questionnaire survey of patients' satisfaction rate and requirement of aperients was undertaken. RESULTS: Mean age and symptom duration were respectively 41 and 20 years. Half of patients reported fewer than 3 bowel motions per week. Patients were treated with a mean of 5 biofeedback sessions. At the end of the therapy pelvic floor dyssynergia was alleviated in 85% of patients and 49% were able to stop all aperients. Satisfaction was maintained at follow-up telephone interviews undertaken after a mean period of 2 years, as biofeedback was helpful for 79% of patients and 47% still abstained from intake of aperients. CONCLUSIONS: Satisfaction after biofeedback is high for patients referred for chronic constipation and diagnosed with pelvic floor dyssynergia. Biofeedback improves symptoms related to dyschezia and reduces use of aperients.
Assuntos
Biorretroalimentação Psicológica , Constipação Intestinal/terapia , Satisfação do Paciente , Diafragma da Pelve/fisiopatologia , Adulto , Doença Crônica , Constipação Intestinal/fisiopatologia , Feminino , Humanos , Modelos Logísticos , Masculino , Manometria , Inquéritos e QuestionáriosAssuntos
Duodenopatias/complicações , Duodenopatias/terapia , Embolização Terapêutica/métodos , Varizes Esofágicas e Gástricas/complicações , Varizes Esofágicas e Gástricas/terapia , Hemorragia Gastrointestinal/etiologia , Portografia/métodos , Radiografia Intervencionista/métodos , Escleroterapia/métodos , Idoso , Duodenopatias/diagnóstico por imagem , Duodenopatias/etiologia , Varizes Esofágicas e Gástricas/diagnóstico por imagem , Varizes Esofágicas e Gástricas/etiologia , Humanos , Cirrose Hepática Alcoólica/complicações , Masculino , Ruptura Espontânea , Tomografia Computadorizada por Raios XRESUMO
We here report the case history of a 75-yr-old woman who developed pancreatitis and recurrent symptomatic, cholestasis-induced hemobilia after percutaneous liver biopsy. An endoscopic sphincterotomy with clot extraction led to relief of symptoms. The risk of hemobilia after percutaneous liver biopsy is less than one per 1000 procedures, and only two cases of acute pancreatitis after percutaneous liver biopsy have previously been reported. To our knowledge, this is the first case in which endoscopic retrograde cholangiopancreatography was used to both diagnostic and therapeutic ends.
Assuntos
Biópsia por Agulha/efeitos adversos , Colangiopancreatografia Retrógrada Endoscópica , Hemobilia/etiologia , Fígado/patologia , Pancreatite/etiologia , Doença Aguda , Idoso , Ductos Biliares/lesões , Colestase/diagnóstico por imagem , Colestase/etiologia , Colestase/cirurgia , Feminino , Hemobilia/terapia , Humanos , Cirrose Hepática Biliar/diagnóstico , Pancreatite/diagnóstico , Pancreatite/terapia , Esfinterotomia EndoscópicaRESUMO
The bone density in the spine and femoral neck was measured by dual-energy X-ray absorptiometry in 24 female with anorexia nervosa 14 to 34 y.o. (20.6 +/- 5.5 y.o.). Osteopenia or osteoporosis were always present. All the cases presented with hypogonadotrophic hypogonadism and secondary amenorrhea between 4 and 194 months (40.6 +/- 53.8 months) and with low levels of oestradiol and gonadotrophins. The anorectic patient cumulates hypogonadism and a low intake of calories, calcium and vitamin D, which causes a low body mass index. These factors are more important when present before peak bone mass is reached. The gonadotrophic deficit in the young anorectic male is less obvious clinically than in the young female with amenorrhea but can be however documented with hormonal data. The osteopenia of the anorectic girl can be at least partially corrected with the hormonal and nutritional treatment. In order to reach an adequate peak bone mass in late adolescence or early adulthood and to prevent the development of osteopenia, the male and female anorectic patients should receive a hormonal substitution and an adequate nutritional supply of calcium and vitamin D, as soon as the diagnosis has been made.
Assuntos
Anorexia Nervosa/complicações , Doenças Ósseas Metabólicas/etiologia , Absorciometria de Fóton , Adolescente , Adulto , Anorexia Nervosa/terapia , Índice de Massa Corporal , Densidade Óssea , Doenças Ósseas Metabólicas/diagnóstico por imagem , Feminino , Humanos , Masculino , Cintilografia , Estudos Retrospectivos , Fatores de RiscoRESUMO
A young patient suffering from schizophrenia had intense headaches and photophobia which were induced by intra-ocular injections of mercury. The clinical diagnosis was established once foreign bodies were visualized on regular X-rays of the patients skull. The mercury intoxication in combination with the secondary irreversible lesions to the eyes necessitated a bilateral enucleation and the use of a chelating treatment with sodium-dimercapto-1-propane sulfate (DMP). Automutilation is a very rare and dramatic complication of schizophrenia. The psychiatric handling and meaning of such dramatic automutilation is discussed in this case report together with a recent review of the toxicologic treatment of mercury intoxication in humans.
Assuntos
Corpos Estranhos no Olho/diagnóstico , Intoxicação por Mercúrio/diagnóstico , Esquizofrenia/diagnóstico , Psicologia do Esquizofrênico , Automutilação/diagnóstico , Adulto , Terapia Combinada , Corpos Estranhos no Olho/psicologia , Corpos Estranhos no Olho/terapia , Feminino , Humanos , Injeções , Intoxicação por Mercúrio/psicologia , Intoxicação por Mercúrio/terapia , Equipe de Assistência ao Paciente , Automutilação/psicologiaRESUMO
The authors report two cases of post traumatic haemopericardium discovered 18 days after a iatrogenic penetrating trauma (sternal puncture) for the first one, and 102 days after a fall with blunt thoracic trauma and multiple associated injuries, for the second one. After admission, the first case rapidly developed a severe tamponade requiring a pericardial drainage, of 420 ml of non coagulated blood. The second case, in spite of a volume of liquid of more than 1000 ml, showed only a fatigue and a dyspnea, without any sign of haemodynamic failure. A literature review allows to be more specific about the characteristics of the tamponade and the different mechanisms responsible for cardiac injuries connected to thoracic traumas. For many reasons, the cardiac damages and/or their complications are often misjudged, particularly in thoracic traumas associated with multiple lesions. Among the sequelae, pericarditis, with or without effusion, is particularly frequent and it is essential to systematically look for it before dismissing a patient who went through a thoracic trauma. As for the bone marrow sampling, the sternal puncture generates a great number of injuries and must be proscribed. The iliac crest puncture should take its place.